{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:41:23Z","timestamp":1793900483060,"version":"4.8.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82321002"],"award-info":[{"award-number":["82321002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471870"],"award-info":[{"award-number":["82471870"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["823B2039"],"award-info":[{"award-number":["823B2039"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230056"],"award-info":[{"award-number":["82230056"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024ZD11"],"award-info":[{"award-number":["ZR2024ZD11"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010029","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202507035"],"award-info":[{"award-number":["tsqn202507035"]}],"id":[{"id":"10.13039\/501100010029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jhep.2026.04.010","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:12:49Z","timestamp":1777011169000},"page":"331-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tim-3 facilitates dendritic cell ferroptosis and impairs antitumor immunity in steatohepatitis-related HCC"],"prefix":"10.1016","volume":"85","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyan","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tixiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuanchang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2404-7439","authenticated-orcid":false,"given":"Lifen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7626-3478","authenticated-orcid":false,"given":"Xiaohong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5798-2274","authenticated-orcid":false,"given":"Chunyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8121-4718","authenticated-orcid":false,"given":"Chunhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.jhep.2026.04.010_bib1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.010_bib2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and management of hepatocellular carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.010_bib3","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2020.05.042","article-title":"Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance","volume":"73","author":"Mak","year":"2020","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.jhep.2026.04.010_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7854","key":"10.1016\/j.jhep.2026.04.010_bib5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.04.010_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and disease spectrum","volume":"11","author":"Hardy","year":"2016","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.010_bib7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.28368","article-title":"Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study","volume":"63","author":"Piscaglia","year":"2016","journal-title":"Hepatology"},{"issue":"7593","key":"10.1016\/j.jhep.2026.04.010_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"issue":"7680","key":"10.1016\/j.jhep.2026.04.010_bib9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.010_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.010_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41571-024-00859-1","article-title":"Dendritic cells as orchestrators of anticancer immunity and immunotherapy","volume":"21","author":"Heras-Murillo","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.jhep.2026.04.010_bib12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"issue":"70","key":"10.1016\/j.jhep.2026.04.010_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abm9409","article-title":"Human dendritic cells in cancer","volume":"7","author":"Kvedaraite","year":"2022","journal-title":"Sci Immunol"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.010_bib14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.010_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41423-021-00753-1","article-title":"Metabolic programming in dendritic cells tailors immune responses and homeostasis","volume":"19","author":"Moller","year":"2022","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.010_bib16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1053\/j.gastro.2012.06.003","article-title":"Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver","volume":"143","author":"Ibrahim","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.010_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.immuni.2017.12.004","article-title":"Paracrine Wnt5a-beta-catenin signaling triggers a metabolic program that drives dendritic cell tolerization","volume":"48","author":"Zhao","year":"2018","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.jhep.2026.04.010_bib18","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","article-title":"ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis","volume":"161","author":"Cubillos-Ruiz","year":"2015","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.jhep.2026.04.010_bib19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.010_bib20","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.4049\/jimmunol.1302801","article-title":"Oxidized lipids block antigen cross-presentation by dendritic cells in cancer","volume":"192","author":"Ramakrishnan","year":"2014","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.010_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4049\/jimmunol.1701024","article-title":"Dendritic cell-based cancer vaccines","volume":"200","author":"Santos","year":"2018","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.010_bib22","article-title":"CXCL9\/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer","volume":"5","author":"Lim","year":"2024","journal-title":"Cell Rep Med"},{"issue":"10126","key":"10.1016\/j.jhep.2026.04.010_bib23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib vs. sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jhep.2026.04.010_bib24","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.010_bib25","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","article-title":"Molecular and histological correlations in liver cancer","volume":"71","author":"Calderaro","year":"2019","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.jhep.2026.04.010_bib26","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/PAS.0b013e3181f31caa","article-title":"Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD\/NASH","volume":"34","author":"Salomao","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"722","key":"10.1016\/j.jhep.2026.04.010_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg6752","article-title":"Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models","volume":"15","author":"Ma","year":"2023","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.010_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"Plos Biol"},{"issue":"15","key":"10.1016\/j.jhep.2026.04.010_bib29","doi-asserted-by":"crossref","first-page":"5681","DOI":"10.7150\/ijbs.65044","article-title":"Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies","volume":"18","author":"Fang","year":"2022","journal-title":"Int J Biol Sci"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.010_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","article-title":"A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma","volume":"46","author":"Fujii","year":"2013","journal-title":"Med Mol Morphol"},{"issue":"534","key":"10.1016\/j.jhep.2026.04.010_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav7431","article-title":"Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy","volume":"12","author":"Mayoux","year":"2020","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.jhep.2026.04.010_bib32","article-title":"Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8(+) T cell exhaustion and anti-PD-1 resistance","volume":"5","author":"Chen","year":"2024","journal-title":"Cell Rep Med"},{"issue":"7854","key":"10.1016\/j.jhep.2026.04.010_bib33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.010_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"10.1016\/j.jhep.2026.04.010_bib35","article-title":"TNFR1 signaling promotes pancreatic tumor growth by limiting dendritic cell number and function","volume":"5","author":"Alam","year":"2024","journal-title":"Cell Rep Med"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.010_bib36","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.jhep.2026.04.010_bib37","first-page":"3827","article-title":"The role of circulating dendritic cells in patients with unresectable pancreatic cancer","volume":"31","author":"Hirooka","year":"2011","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.jhep.2026.04.010_bib38","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41423-024-01215-0","article-title":"Hepatocellular carcinoma-specific epigenetic checkpoints bidirectionally regulate the antitumor immunity of CD4 + T cells","volume":"21","author":"Wang","year":"2024","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.010_bib39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","article-title":"TIM3 comes of age as an inhibitory receptor","volume":"20","author":"Wolf","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.010_bib40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ccell.2017.11.019","article-title":"TIM-3 regulates CD103(+) dendritic cell function and response to chemotherapy in breast cancer","volume":"33","author":"De Mingo Pulido","year":"2018","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.010_bib41","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2021.04.019","article-title":"The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake","volume":"54","author":"De Mingo Pulido","year":"2021","journal-title":"Immunity"},{"issue":"7865","key":"10.1016\/j.jhep.2026.04.010_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","article-title":"TIM-3 restrains anti-tumour immunity by regulating inflammasome activation","volume":"595","author":"Dixon","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.010_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003571","article-title":"TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8(+) T cell and XCR1(+) dendritic cell spatial co-localization","volume":"10","author":"Gardner","year":"2022","journal-title":"J Immunother Cancer"},{"issue":"11","key":"10.1016\/j.jhep.2026.04.010_bib44","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/s41423-018-0032-0","article-title":"Increased Tim-3 expression alleviates liver injury by regulating macrophage activation in MCD-induced NASH mice","volume":"16","author":"Du","year":"2019","journal-title":"Cell Mol Immunol"},{"issue":"8","key":"10.1016\/j.jhep.2026.04.010_bib45","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1038\/s12276-023-01069-y","article-title":"Regulated cell death pathways and their roles in homeostasis, infection, inflammation, and tumorigenesis","volume":"55","author":"Lee","year":"2023","journal-title":"Exp Mol Med"},{"issue":"9","key":"10.1016\/j.jhep.2026.04.010_bib46","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s41418-022-00966-5","article-title":"The lipid peroxidation product 4-hydroxynonenal inhibits NLRP3 inflammasome activation and macrophage pyroptosis","volume":"29","author":"Hsu","year":"2022","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.010_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s43556-025-00267-6","article-title":"TIM-3 teams up with PD-1 in cancer immunotherapy: mechanisms and perspectives","volume":"6","author":"Yan","year":"2025","journal-title":"Mol Biomed"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826002138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826002138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:13:56Z","timestamp":1786486436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827826002138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0168827826002138"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.04.010","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tim-3 facilitates dendritic cell ferroptosis and impairs antitumor immunity in steatohepatitis-related HCC","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}